Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

被引：0

作者：

Bu, Rong ^{[1
]}

Bavi, Prashant ^{[1
]}

Hussain, Azhar R. ^{[1
]}

Jehan, Zeenath ^{[1
]}

Abubaker, Jehad ^{[1
]}

Al-Sanea, Nasser A. ^{[1
]}

Abduljabbar, Alaa S. ^{[1
]}

Ashari, Luai H. ^{[1
]}

Al-Homoud, Samar J. ^{[1
]}

Al-Dayel, Fouad ^{[1
]}

George, Thara ^{[1
]}

Qadri, Zeeshan ^{[1
]}

Hassan, Nurul ^{[1
]}

Prabhakaran, Sarita E. ^{[1
]}

Ahmed, Magbool ^{[1
]}

Uddin, Shahab ^{[1
]}

Al-Kuraya, Khawla S. ^{[1
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-2980

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2980

引用

页数：1

共 50 条

[41] UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy [J].

Morikawa, Teppei ;

Kawai, Taketo ;

Abe, Hiroyuki ;

Kume, Haruki ;

Homma, Yukio ;

Fukayama, Masashi .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (07) :1367-1374

[42] Identification of small molecule inhibitors against UBE2C by using docking studies [J].

Sabitha, Kesavan ;

Rajkumar, Thangarajan .

BIOINFORMATION, 2012, 8 (21) :1047-1058

[43] Overexpression of UBE2C Correlates to Immune Infiltration and Poor Prognosis: A Potential Prognostic Biomarker and Promoting Therapeutic Target for Papillary Renal Cell Carcinoma [J].

Sun, Qingyang ;

Fu, Yao ;

Fan, Xiangshan .

LABORATORY INVESTIGATION, 2023, 103 (03) :S807-S808

[44] Synergistic inhibition of the APC/C by the removal of APC15 in HCT116 cells lacking UBE2C [J].

Garvanska, Dimitriya H. ;

Larsen, Marie Sofie Yoo ;

Nilsson, Jakob .

BIOLOGY OPEN, 2016, 5 (10) :1441-1448

[45] UBE2C triggers HIF-1α-glycolytic flux in head and neck squamous cell carcinoma [J].

Yang, Yi-Fang ;

Chang, Yu-Chan ;

Tsai, Kuo-Wang ;

Hung, Ming-Hsin ;

Kang, Bor-Hwang .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (13) :3716-3725

[46] UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway [J].

Lu, Zi-Nan ;

Song, Jia ;

Sun, Tong-Hui ;

Sun, Gang .

CHINESE MEDICAL JOURNAL, 2021, 134 (20) :2465-2474

[47] UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability [J].

Zhang, Jun ;

Liu, Xinyu ;

Yu, Guanzhen ;

Liu, Lei ;

Wang, Jiejun ;

Chen, Xiaoyu ;

Bian, Yuhai ;

Ji, Yuan ;

Zhou, Xiaoyan ;

Chen, Yinan ;

Ji, Jun ;

Xiang, Zhen ;

Guo, Lei ;

Fang, Jingyuan ;

Sun, Yihong ;

Cao, Hui ;

Zhu, Zhenggang ;

Yu, Yingyan .

FRONTIERS IN PHARMACOLOGY, 2018, 9

[48] Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma [J].

Alafate, Wahafu ;

Zuo, Jie ;

Deng, Zhong ;

Guo, Xiaoye ;

Wu, Wei ;

Zhang, Wei ;

Xie, Wanfu ;

Wang, Maode ;

Wang, Jia .

PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (10)

[49] UBE2C overexpression in melanoma and its essential role in G2/M transition [J].

Liu, Guolong ;

Zhao, Jun ;

Pan, Boyu ;

Ma, Gang ;

Liu, Liren .

JOURNAL OF CANCER, 2019, 10 (10) :2176-2184

[50] Targeting UBE2C for degradation by bioPROTACs based on bacterial E3 ligase [J].

Jinpeng Wang ;

Min Zhang ;

Susheng Liu ;

Zhipeng He ;

Rui Wang ;

Minchan Liang ;

Yuhao An ;

Chenran Jiang ;

Chunli Song ;

Zigong Ning ;

Feng Yin ;

Hao Huang ;

Zigang Li ;

Yuxin Ye .

Chinese Chemical Letters, 2023, 34 (04) :243-247

← 1 2 3 4 5 →